Mount Sinai researchers receive NIH grant to compare new treatment options for sickle cell disease

The Mount Sinai Health System has received a $12,180,625 grant from the National Heart, Lung and Blood Institute to compare new treatment options for sickle cell disease and determine which work best for specific patients.

Why the Importer of Record (IoR) is vital in the clinical supply chain

An Importer of Record (IoR) performs a crucial role in the clinical supply chain. Credit: Dragana Gordic via Shutterstock. With imports fundamental to the clinical

September 3, 2024

‘Jerking families around’: Canceled Roche rare disease trial devastates parents, angers researchers

Roche, the Swiss pharmaceutical giant, earlier this year abruptly cancelled an international clinical trial of a drug being studied to treat children with a rare

August 6, 2024

Roche looks to have a competitive GLP-1 drug

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. The weather

July 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.